nodes	percent_of_prediction	percent_of_DWPC	metapath
Alfuzosin—CYP3A4—Temozolomide—brain cancer	0.261	0.486	CbGbCtD
Alfuzosin—CYP3A4—Lomustine—brain cancer	0.222	0.414	CbGbCtD
Alfuzosin—CYP3A4—Etoposide—brain cancer	0.0537	0.0999	CbGbCtD
Alfuzosin—Osteoarthritis—Lomustine—brain cancer	0.00896	0.0193	CcSEcCtD
Alfuzosin—Neuropathy—Procarbazine—brain cancer	0.00736	0.0159	CcSEcCtD
Alfuzosin—Influenza-like symptoms—Temozolomide—brain cancer	0.00663	0.0143	CcSEcCtD
Alfuzosin—Cholestasis—Temozolomide—brain cancer	0.00624	0.0135	CcSEcCtD
Alfuzosin—Liver injury—Temozolomide—brain cancer	0.00563	0.0122	CcSEcCtD
Alfuzosin—Toxic epidermal necrolysis—Procarbazine—brain cancer	0.00512	0.0111	CcSEcCtD
Alfuzosin—Infection—Carboplatin—brain cancer	0.005	0.0108	CcSEcCtD
Alfuzosin—Angina pectoris—Procarbazine—brain cancer	0.00479	0.0103	CcSEcCtD
Alfuzosin—Neuropathy—Carmustine—brain cancer	0.0046	0.00994	CcSEcCtD
Alfuzosin—Influenza like illness—Temozolomide—brain cancer	0.0046	0.00994	CcSEcCtD
Alfuzosin—Neuropathy—Temozolomide—brain cancer	0.00445	0.00961	CcSEcCtD
Alfuzosin—Drowsiness—Procarbazine—brain cancer	0.00438	0.00947	CcSEcCtD
Alfuzosin—Infection—Lomustine—brain cancer	0.00437	0.00945	CcSEcCtD
Alfuzosin—Cardiovascular disorder—Etoposide—brain cancer	0.00431	0.00932	CcSEcCtD
Alfuzosin—Thrombocytopenia—Lomustine—brain cancer	0.00431	0.00931	CcSEcCtD
Alfuzosin—Pain—Carboplatin—brain cancer	0.0043	0.0093	CcSEcCtD
Alfuzosin—Neuropathy peripheral—Procarbazine—brain cancer	0.0043	0.00928	CcSEcCtD
Alfuzosin—Jaundice—Procarbazine—brain cancer	0.00427	0.00923	CcSEcCtD
Alfuzosin—Sweating—Procarbazine—brain cancer	0.0042	0.00908	CcSEcCtD
Alfuzosin—Breast disorder—Hydroxyurea—brain cancer	0.00398	0.00859	CcSEcCtD
Alfuzosin—Injury—Carmustine—brain cancer	0.00387	0.00836	CcSEcCtD
Alfuzosin—Flushing—Procarbazine—brain cancer	0.00365	0.00789	CcSEcCtD
Alfuzosin—Neuropathy—Etoposide—brain cancer	0.00356	0.00769	CcSEcCtD
Alfuzosin—Infestation NOS—Hydroxyurea—brain cancer	0.00339	0.00733	CcSEcCtD
Alfuzosin—Infestation—Hydroxyurea—brain cancer	0.00339	0.00733	CcSEcCtD
Alfuzosin—Drowsiness—Hydroxyurea—brain cancer	0.00339	0.00733	CcSEcCtD
Alfuzosin—Neuropathy peripheral—Hydroxyurea—brain cancer	0.00333	0.00718	CcSEcCtD
Alfuzosin—Hepatobiliary disease—Hydroxyurea—brain cancer	0.00321	0.00693	CcSEcCtD
Alfuzosin—Breast disorder—Temozolomide—brain cancer	0.00311	0.00671	CcSEcCtD
Alfuzosin—Toxic epidermal necrolysis—Temozolomide—brain cancer	0.0031	0.00669	CcSEcCtD
Alfuzosin—Syncope—Procarbazine—brain cancer	0.00307	0.00663	CcSEcCtD
Alfuzosin—Loss of consciousness—Procarbazine—brain cancer	0.00301	0.0065	CcSEcCtD
Alfuzosin—Arthralgia—Procarbazine—brain cancer	0.00292	0.0063	CcSEcCtD
Alfuzosin—Bronchitis—Temozolomide—brain cancer	0.00286	0.00617	CcSEcCtD
Alfuzosin—Dry mouth—Procarbazine—brain cancer	0.00285	0.00616	CcSEcCtD
Alfuzosin—Vomiting—Lomustine—brain cancer	0.0028	0.00605	CcSEcCtD
Alfuzosin—Oedema—Procarbazine—brain cancer	0.0028	0.00604	CcSEcCtD
Alfuzosin—Infection—Procarbazine—brain cancer	0.00278	0.006	CcSEcCtD
Alfuzosin—Angiopathy—Hydroxyurea—brain cancer	0.00276	0.00597	CcSEcCtD
Alfuzosin—Upper respiratory tract infection—Temozolomide—brain cancer	0.00276	0.00597	CcSEcCtD
Alfuzosin—Shock—Procarbazine—brain cancer	0.00275	0.00594	CcSEcCtD
Alfuzosin—Erectile dysfunction—Temozolomide—brain cancer	0.00274	0.00591	CcSEcCtD
Alfuzosin—Thrombocytopenia—Procarbazine—brain cancer	0.00274	0.00591	CcSEcCtD
Alfuzosin—Tachycardia—Procarbazine—brain cancer	0.00273	0.00589	CcSEcCtD
Alfuzosin—Hyperhidrosis—Procarbazine—brain cancer	0.0027	0.00584	CcSEcCtD
Alfuzosin—Neuropathy peripheral—Carmustine—brain cancer	0.00269	0.00581	CcSEcCtD
Alfuzosin—Infestation NOS—Temozolomide—brain cancer	0.00265	0.00572	CcSEcCtD
Alfuzosin—Infestation—Temozolomide—brain cancer	0.00265	0.00572	CcSEcCtD
Alfuzosin—Nausea—Lomustine—brain cancer	0.00262	0.00565	CcSEcCtD
Alfuzosin—Hypotension—Procarbazine—brain cancer	0.00261	0.00564	CcSEcCtD
Alfuzosin—Neuropathy peripheral—Temozolomide—brain cancer	0.0026	0.00561	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Procarbazine—brain cancer	0.00255	0.0055	CcSEcCtD
Alfuzosin—Hepatobiliary disease—Temozolomide—brain cancer	0.00251	0.00541	CcSEcCtD
Alfuzosin—Sinusitis—Temozolomide—brain cancer	0.00249	0.00537	CcSEcCtD
Alfuzosin—Somnolence—Procarbazine—brain cancer	0.00249	0.00537	CcSEcCtD
Alfuzosin—Toxic epidermal necrolysis—Etoposide—brain cancer	0.00248	0.00535	CcSEcCtD
Alfuzosin—Ill-defined disorder—Hydroxyurea—brain cancer	0.00246	0.00531	CcSEcCtD
Alfuzosin—Connective tissue disorder—Carmustine—brain cancer	0.00242	0.00522	CcSEcCtD
Alfuzosin—Fatigue—Procarbazine—brain cancer	0.00241	0.00521	CcSEcCtD
Alfuzosin—Malaise—Hydroxyurea—brain cancer	0.00239	0.00516	CcSEcCtD
Alfuzosin—Constipation—Procarbazine—brain cancer	0.00239	0.00516	CcSEcCtD
Alfuzosin—Pain—Procarbazine—brain cancer	0.00239	0.00516	CcSEcCtD
Alfuzosin—Pharyngitis—Temozolomide—brain cancer	0.00236	0.0051	CcSEcCtD
Alfuzosin—Urinary tract disorder—Temozolomide—brain cancer	0.00235	0.00507	CcSEcCtD
Alfuzosin—Connective tissue disorder—Temozolomide—brain cancer	0.00234	0.00505	CcSEcCtD
Alfuzosin—Urethral disorder—Temozolomide—brain cancer	0.00233	0.00504	CcSEcCtD
Alfuzosin—Feeling abnormal—Procarbazine—brain cancer	0.0023	0.00498	CcSEcCtD
Alfuzosin—Eye disorder—Carmustine—brain cancer	0.0023	0.00497	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Procarbazine—brain cancer	0.00229	0.00494	CcSEcCtD
Alfuzosin—Flushing—Carmustine—brain cancer	0.00228	0.00493	CcSEcCtD
Alfuzosin—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.00224	0.00484	CcSEcCtD
Alfuzosin—Discomfort—Hydroxyurea—brain cancer	0.00223	0.00482	CcSEcCtD
Alfuzosin—Eye disorder—Temozolomide—brain cancer	0.00222	0.0048	CcSEcCtD
Alfuzosin—Urticaria—Procarbazine—brain cancer	0.00222	0.0048	CcSEcCtD
Alfuzosin—Abdominal pain—Procarbazine—brain cancer	0.00221	0.00477	CcSEcCtD
Alfuzosin—Cardiac disorder—Temozolomide—brain cancer	0.00221	0.00477	CcSEcCtD
Alfuzosin—Flushing—Temozolomide—brain cancer	0.00221	0.00477	CcSEcCtD
Alfuzosin—Oedema—Hydroxyurea—brain cancer	0.00216	0.00467	CcSEcCtD
Alfuzosin—Angiopathy—Temozolomide—brain cancer	0.00216	0.00466	CcSEcCtD
Alfuzosin—Mental disorder—Carmustine—brain cancer	0.00216	0.00466	CcSEcCtD
Alfuzosin—Infection—Hydroxyurea—brain cancer	0.00215	0.00464	CcSEcCtD
Alfuzosin—Mediastinal disorder—Temozolomide—brain cancer	0.00214	0.00463	CcSEcCtD
Alfuzosin—Nervous system disorder—Hydroxyurea—brain cancer	0.00212	0.00458	CcSEcCtD
Alfuzosin—Infestation NOS—Etoposide—brain cancer	0.00212	0.00458	CcSEcCtD
Alfuzosin—Infestation—Etoposide—brain cancer	0.00212	0.00458	CcSEcCtD
Alfuzosin—Thrombocytopenia—Hydroxyurea—brain cancer	0.00212	0.00458	CcSEcCtD
Alfuzosin—Skin disorder—Hydroxyurea—brain cancer	0.0021	0.00454	CcSEcCtD
Alfuzosin—Mental disorder—Temozolomide—brain cancer	0.00208	0.0045	CcSEcCtD
Alfuzosin—Neuropathy peripheral—Etoposide—brain cancer	0.00208	0.00449	CcSEcCtD
Alfuzosin—Back pain—Carmustine—brain cancer	0.00207	0.00448	CcSEcCtD
Alfuzosin—Jaundice—Etoposide—brain cancer	0.00207	0.00446	CcSEcCtD
Alfuzosin—Asthenia—Procarbazine—brain cancer	0.00201	0.00433	CcSEcCtD
Alfuzosin—Hepatobiliary disease—Etoposide—brain cancer	0.00201	0.00433	CcSEcCtD
Alfuzosin—Back pain—Temozolomide—brain cancer	0.002	0.00433	CcSEcCtD
Alfuzosin—Pruritus—Procarbazine—brain cancer	0.00198	0.00427	CcSEcCtD
Alfuzosin—Somnolence—Hydroxyurea—brain cancer	0.00192	0.00415	CcSEcCtD
Alfuzosin—Ill-defined disorder—Temozolomide—brain cancer	0.00192	0.00415	CcSEcCtD
Alfuzosin—Diarrhoea—Procarbazine—brain cancer	0.00191	0.00413	CcSEcCtD
Alfuzosin—Dyspepsia—Hydroxyurea—brain cancer	0.0019	0.00411	CcSEcCtD
Alfuzosin—Angioedema—Temozolomide—brain cancer	0.00189	0.00409	CcSEcCtD
Alfuzosin—Urinary tract disorder—Etoposide—brain cancer	0.00188	0.00406	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.00187	0.00403	CcSEcCtD
Alfuzosin—Malaise—Temozolomide—brain cancer	0.00187	0.00403	CcSEcCtD
Alfuzosin—Urethral disorder—Etoposide—brain cancer	0.00187	0.00403	CcSEcCtD
Alfuzosin—Fatigue—Hydroxyurea—brain cancer	0.00187	0.00403	CcSEcCtD
Alfuzosin—Vertigo—Temozolomide—brain cancer	0.00186	0.00402	CcSEcCtD
Alfuzosin—Pain—Hydroxyurea—brain cancer	0.00185	0.004	CcSEcCtD
Alfuzosin—Constipation—Hydroxyurea—brain cancer	0.00185	0.004	CcSEcCtD
Alfuzosin—Dizziness—Procarbazine—brain cancer	0.00185	0.00399	CcSEcCtD
Alfuzosin—Palpitations—Temozolomide—brain cancer	0.00183	0.00395	CcSEcCtD
Alfuzosin—Chest pain—Carmustine—brain cancer	0.00182	0.00394	CcSEcCtD
Alfuzosin—Feeling abnormal—Hydroxyurea—brain cancer	0.00178	0.00385	CcSEcCtD
Alfuzosin—Eye disorder—Etoposide—brain cancer	0.00178	0.00384	CcSEcCtD
Alfuzosin—Vomiting—Procarbazine—brain cancer	0.00178	0.00384	CcSEcCtD
Alfuzosin—Cardiac disorder—Etoposide—brain cancer	0.00177	0.00382	CcSEcCtD
Alfuzosin—Flushing—Etoposide—brain cancer	0.00177	0.00382	CcSEcCtD
Alfuzosin—Arthralgia—Temozolomide—brain cancer	0.00176	0.00381	CcSEcCtD
Alfuzosin—Rash—Procarbazine—brain cancer	0.00176	0.00381	CcSEcCtD
Alfuzosin—Dermatitis—Procarbazine—brain cancer	0.00176	0.0038	CcSEcCtD
Alfuzosin—Headache—Procarbazine—brain cancer	0.00175	0.00378	CcSEcCtD
Alfuzosin—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.00175	0.00378	CcSEcCtD
Alfuzosin—Oedema—Carmustine—brain cancer	0.00175	0.00378	CcSEcCtD
Alfuzosin—Discomfort—Temozolomide—brain cancer	0.00174	0.00376	CcSEcCtD
Alfuzosin—Infection—Carmustine—brain cancer	0.00174	0.00375	CcSEcCtD
Alfuzosin—Angiopathy—Etoposide—brain cancer	0.00173	0.00373	CcSEcCtD
Alfuzosin—Dry mouth—Temozolomide—brain cancer	0.00172	0.00372	CcSEcCtD
Alfuzosin—Mediastinal disorder—Etoposide—brain cancer	0.00172	0.00371	CcSEcCtD
Alfuzosin—Thrombocytopenia—Carmustine—brain cancer	0.00171	0.0037	CcSEcCtD
Alfuzosin—Tachycardia—Carmustine—brain cancer	0.00171	0.00369	CcSEcCtD
Alfuzosin—Oedema—Temozolomide—brain cancer	0.00169	0.00365	CcSEcCtD
Alfuzosin—Infection—Temozolomide—brain cancer	0.00168	0.00363	CcSEcCtD
Alfuzosin—Nausea—Procarbazine—brain cancer	0.00166	0.00359	CcSEcCtD
Alfuzosin—Nervous system disorder—Temozolomide—brain cancer	0.00166	0.00358	CcSEcCtD
Alfuzosin—Thrombocytopenia—Temozolomide—brain cancer	0.00165	0.00357	CcSEcCtD
Alfuzosin—Skin disorder—Temozolomide—brain cancer	0.00164	0.00355	CcSEcCtD
Alfuzosin—Hypotension—Carmustine—brain cancer	0.00163	0.00353	CcSEcCtD
Alfuzosin—Hyperhidrosis—Temozolomide—brain cancer	0.00163	0.00353	CcSEcCtD
Alfuzosin—Back pain—Etoposide—brain cancer	0.0016	0.00346	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Carmustine—brain cancer	0.00159	0.00344	CcSEcCtD
Alfuzosin—Somnolence—Carmustine—brain cancer	0.00155	0.00336	CcSEcCtD
Alfuzosin—Asthenia—Hydroxyurea—brain cancer	0.00155	0.00335	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Temozolomide—brain cancer	0.00154	0.00333	CcSEcCtD
Alfuzosin—Ill-defined disorder—Etoposide—brain cancer	0.00154	0.00332	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Carmustine—brain cancer	0.00151	0.00326	CcSEcCtD
Alfuzosin—Somnolence—Temozolomide—brain cancer	0.0015	0.00325	CcSEcCtD
Alfuzosin—Pain—Carmustine—brain cancer	0.0015	0.00323	CcSEcCtD
Alfuzosin—Constipation—Carmustine—brain cancer	0.0015	0.00323	CcSEcCtD
Alfuzosin—Malaise—Etoposide—brain cancer	0.00149	0.00323	CcSEcCtD
Alfuzosin—Vertigo—Etoposide—brain cancer	0.00149	0.00322	CcSEcCtD
Alfuzosin—Dyspepsia—Temozolomide—brain cancer	0.00149	0.00321	CcSEcCtD
Alfuzosin—Diarrhoea—Hydroxyurea—brain cancer	0.00148	0.0032	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Temozolomide—brain cancer	0.00146	0.00315	CcSEcCtD
Alfuzosin—Fatigue—Temozolomide—brain cancer	0.00146	0.00315	CcSEcCtD
Alfuzosin—Loss of consciousness—Etoposide—brain cancer	0.00146	0.00315	CcSEcCtD
Alfuzosin—Pain—Temozolomide—brain cancer	0.00145	0.00312	CcSEcCtD
Alfuzosin—Constipation—Temozolomide—brain cancer	0.00145	0.00312	CcSEcCtD
Alfuzosin—Feeling abnormal—Carmustine—brain cancer	0.00144	0.00311	CcSEcCtD
Alfuzosin—Dizziness—Hydroxyurea—brain cancer	0.00143	0.00309	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Carmustine—brain cancer	0.00143	0.00309	CcSEcCtD
Alfuzosin—Chest pain—Etoposide—brain cancer	0.00141	0.00305	CcSEcCtD
Alfuzosin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.0014	0.00303	CcSEcCtD
Alfuzosin—Discomfort—Etoposide—brain cancer	0.00139	0.00301	CcSEcCtD
Alfuzosin—Feeling abnormal—Temozolomide—brain cancer	0.00139	0.00301	CcSEcCtD
Alfuzosin—Abdominal pain—Carmustine—brain cancer	0.00138	0.00299	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Temozolomide—brain cancer	0.00138	0.00299	CcSEcCtD
Alfuzosin—Vomiting—Hydroxyurea—brain cancer	0.00138	0.00297	CcSEcCtD
Alfuzosin—Rash—Hydroxyurea—brain cancer	0.00136	0.00295	CcSEcCtD
Alfuzosin—Dermatitis—Hydroxyurea—brain cancer	0.00136	0.00294	CcSEcCtD
Alfuzosin—Headache—Hydroxyurea—brain cancer	0.00136	0.00293	CcSEcCtD
Alfuzosin—Infection—Etoposide—brain cancer	0.00134	0.0029	CcSEcCtD
Alfuzosin—Urticaria—Temozolomide—brain cancer	0.00134	0.0029	CcSEcCtD
Alfuzosin—Abdominal pain—Temozolomide—brain cancer	0.00134	0.00289	CcSEcCtD
Alfuzosin—Thrombocytopenia—Etoposide—brain cancer	0.00132	0.00286	CcSEcCtD
Alfuzosin—Tachycardia—Etoposide—brain cancer	0.00132	0.00285	CcSEcCtD
Alfuzosin—Skin disorder—Etoposide—brain cancer	0.00131	0.00284	CcSEcCtD
Alfuzosin—Hyperhidrosis—Etoposide—brain cancer	0.00131	0.00282	CcSEcCtD
Alfuzosin—Nausea—Hydroxyurea—brain cancer	0.00129	0.00278	CcSEcCtD
Alfuzosin—Hypotension—Etoposide—brain cancer	0.00126	0.00273	CcSEcCtD
Alfuzosin—Asthenia—Carmustine—brain cancer	0.00125	0.00271	CcSEcCtD
Alfuzosin—Asthenia—Temozolomide—brain cancer	0.00121	0.00262	CcSEcCtD
Alfuzosin—Somnolence—Etoposide—brain cancer	0.0012	0.0026	CcSEcCtD
Alfuzosin—Diarrhoea—Carmustine—brain cancer	0.0012	0.00258	CcSEcCtD
Alfuzosin—Pruritus—Temozolomide—brain cancer	0.0012	0.00258	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Etoposide—brain cancer	0.00117	0.00252	CcSEcCtD
Alfuzosin—Fatigue—Etoposide—brain cancer	0.00117	0.00252	CcSEcCtD
Alfuzosin—Dizziness—Carmustine—brain cancer	0.00116	0.0025	CcSEcCtD
Alfuzosin—Pain—Etoposide—brain cancer	0.00116	0.0025	CcSEcCtD
Alfuzosin—Constipation—Etoposide—brain cancer	0.00116	0.0025	CcSEcCtD
Alfuzosin—Diarrhoea—Temozolomide—brain cancer	0.00116	0.0025	CcSEcCtD
Alfuzosin—Dizziness—Temozolomide—brain cancer	0.00112	0.00241	CcSEcCtD
Alfuzosin—Feeling abnormal—Etoposide—brain cancer	0.00111	0.00241	CcSEcCtD
Alfuzosin—Vomiting—Carmustine—brain cancer	0.00111	0.0024	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Etoposide—brain cancer	0.00111	0.00239	CcSEcCtD
Alfuzosin—Rash—Carmustine—brain cancer	0.0011	0.00238	CcSEcCtD
Alfuzosin—Dermatitis—Carmustine—brain cancer	0.0011	0.00238	CcSEcCtD
Alfuzosin—Headache—Carmustine—brain cancer	0.0011	0.00237	CcSEcCtD
Alfuzosin—Vomiting—Temozolomide—brain cancer	0.00107	0.00232	CcSEcCtD
Alfuzosin—Urticaria—Etoposide—brain cancer	0.00107	0.00232	CcSEcCtD
Alfuzosin—Abdominal pain—Etoposide—brain cancer	0.00107	0.00231	CcSEcCtD
Alfuzosin—Rash—Temozolomide—brain cancer	0.00107	0.0023	CcSEcCtD
Alfuzosin—Dermatitis—Temozolomide—brain cancer	0.00106	0.0023	CcSEcCtD
Alfuzosin—Headache—Temozolomide—brain cancer	0.00106	0.00229	CcSEcCtD
Alfuzosin—Nausea—Carmustine—brain cancer	0.00104	0.00224	CcSEcCtD
Alfuzosin—Nausea—Temozolomide—brain cancer	0.001	0.00217	CcSEcCtD
Alfuzosin—Asthenia—Etoposide—brain cancer	0.00097	0.0021	CcSEcCtD
Alfuzosin—Pruritus—Etoposide—brain cancer	0.000957	0.00207	CcSEcCtD
Alfuzosin—Diarrhoea—Etoposide—brain cancer	0.000925	0.002	CcSEcCtD
Alfuzosin—Dizziness—Etoposide—brain cancer	0.000894	0.00193	CcSEcCtD
Alfuzosin—Vomiting—Etoposide—brain cancer	0.00086	0.00186	CcSEcCtD
Alfuzosin—Rash—Etoposide—brain cancer	0.000853	0.00184	CcSEcCtD
Alfuzosin—Dermatitis—Etoposide—brain cancer	0.000852	0.00184	CcSEcCtD
Alfuzosin—Headache—Etoposide—brain cancer	0.000847	0.00183	CcSEcCtD
Alfuzosin—Nausea—Etoposide—brain cancer	0.000803	0.00174	CcSEcCtD
